Confluence Wealth Services Inc. Has $305,000 Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Confluence Wealth Services Inc. lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.1% in the 4th quarter, Holdings Channel.com reports. The fund owned 585 shares of the medical equipment provider’s stock after selling 88 shares during the period. Confluence Wealth Services Inc.’s holdings in Intuitive Surgical were worth $305,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the business. Mirae Asset Global Investments Co. Ltd. raised its position in Intuitive Surgical by 9.8% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 202,275 shares of the medical equipment provider’s stock worth $107,371,000 after purchasing an additional 18,052 shares during the last quarter. Lockheed Martin Investment Management Co. increased its stake in shares of Intuitive Surgical by 18.9% in the fourth quarter. Lockheed Martin Investment Management Co. now owns 10,070 shares of the medical equipment provider’s stock valued at $5,256,000 after buying an additional 1,600 shares during the period. Jackson Wealth Management LLC raised its position in shares of Intuitive Surgical by 46.3% during the fourth quarter. Jackson Wealth Management LLC now owns 1,027 shares of the medical equipment provider’s stock worth $536,000 after acquiring an additional 325 shares during the last quarter. Weaver Capital Management LLC lifted its stake in shares of Intuitive Surgical by 10.7% in the fourth quarter. Weaver Capital Management LLC now owns 2,578 shares of the medical equipment provider’s stock worth $1,346,000 after acquiring an additional 249 shares during the period. Finally, Stratos Investment Management LLC bought a new stake in Intuitive Surgical in the fourth quarter valued at approximately $215,000. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. This trade represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 28,843 shares of company stock valued at $15,357,560. 0.80% of the stock is owned by insiders.

Intuitive Surgical Stock Up 1.9 %

Shares of Intuitive Surgical stock opened at $590.90 on Thursday. The company has a market cap of $210.47 billion, a PE ratio of 92.18, a price-to-earnings-growth ratio of 5.51 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The business has a 50 day moving average price of $551.99 and a 200-day moving average price of $512.04.

Analysts Set New Price Targets

ISRG has been the topic of a number of recent analyst reports. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Stifel Nicolaus boosted their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. Leerink Partners increased their price target on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. BTIG Research upped their target price on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Finally, Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.